These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 21860334

  • 1. Kit for preparation of multimeric receptor-specific ⁹⁹mTc-radiopharmaceuticals based on gold nanoparticles.
    Ocampo-García B, Ferro-Flores G, Morales-Avila E, Ramírez Fde M.
    Nucl Med Commun; 2011 Nov; 32(11):1095-104. PubMed ID: 21860334
    [Abstract] [Full Text] [Related]

  • 2. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
    Mendoza-Sánchez AN, Ferro-Flores G, Ocampo-García BE, Morales-Avila E, de M Ramírez F, De León-Rodríguez LM, Santos-Cuevas CL, Medina LA, Rojas-Calderón EL, Camacho-López MA.
    J Biomed Nanotechnol; 2010 Aug; 6(4):375-84. PubMed ID: 21323111
    [Abstract] [Full Text] [Related]

  • 3. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 4. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
    Morales-Avila E, Ferro-Flores G, Ocampo-García BE, De León-Rodríguez LM, Santos-Cuevas CL, García-Becerra R, Medina LA, Gómez-Oliván L.
    Bioconjug Chem; 2011 May 18; 22(5):913-22. PubMed ID: 21513349
    [Abstract] [Full Text] [Related]

  • 5. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
    Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.
    Nucl Med Commun; 2006 Apr 18; 27(4):371-6. PubMed ID: 16531924
    [Abstract] [Full Text] [Related]

  • 6. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N, Ferro-Flores G, Santos-Cuevas C, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Isaac-Olivé K, Camacho-López M, Torres-García E.
    J Labelled Comp Radiopharm; 2013 Nov 18; 56(13):663-71. PubMed ID: 25196028
    [Abstract] [Full Text] [Related]

  • 7. Improved kit formulation for preparation of (99m)Tc-HYNIC-TOC: results of preliminary clinical evaluation in imaging patients with neuroendocrine tumors.
    Korde A, Mallia M, Shinto A, Sarma HD, Samuel G, Banerjee S.
    Cancer Biother Radiopharm; 2014 Nov 18; 29(9):387-94. PubMed ID: 25379612
    [Abstract] [Full Text] [Related]

  • 8. Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
    Aranda-Lara L, Ferro-Flores G, Ramírez Fde M, Ocampo-García B, Santos-Cuevas C, Díaz-Nieto L, Isaac-Olivé K.
    Nucl Med Commun; 2016 Apr 18; 37(4):377-86. PubMed ID: 26657220
    [Abstract] [Full Text] [Related]

  • 9. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis.
    Guggenberg EV, Mikolajczak R, Janota B, Riccabona G, Decristoforo C.
    J Pharm Sci; 2004 Oct 18; 93(10):2497-506. PubMed ID: 15349959
    [Abstract] [Full Text] [Related]

  • 10. Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.
    Orocio-Rodríguez E, Ferro-Flores G, Santos-Cuevas CL, Ramírez Fde M, Ocampo-García BE, Azorín-Vega E, Sánchez-García FM.
    J Nanosci Nanotechnol; 2015 Jun 18; 15(6):4159-69. PubMed ID: 26369025
    [Abstract] [Full Text] [Related]

  • 11. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 12. Technetium-Radiolabeled Mannose-Functionalized Gold Nanoparticles as Nanoprobes for Sentinel Lymph Node Detection.
    Estudiante-Mariquez OJ, Rodríguez-Galván A, Ramírez-Hernández D, Contreras-Torres FF, Medina LA.
    Molecules; 2020 Apr 23; 25(8):. PubMed ID: 32340310
    [Abstract] [Full Text] [Related]

  • 13. Specificity and sensitivity of ⁹⁹mTc-EDDA/HYNIC-Tyr³-octreotide (⁹⁹mTc-TOC) for imaging neuroendocrine tumors.
    Sepúlveda-Méndez J, de Murphy CA, Pedraza-López M, Murphy-Stack E, Rojas-Bautista JC, González-Treviño O.
    Nucl Med Commun; 2012 Jan 23; 33(1):69-79. PubMed ID: 21970835
    [Abstract] [Full Text] [Related]

  • 14. Laser heating of gold nanospheres functionalized with octreotide: in vitro effect on HeLa cell viability.
    Mendoza-Nava H, Ferro-Flores G, Ocampo-García B, Serment-Guerrero J, Santos-Cuevas C, Jiménez-Mancilla N, Luna-Gutiérrez M, Camacho-López MA.
    Photomed Laser Surg; 2013 Jan 23; 31(1):17-22. PubMed ID: 23140265
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
    Behera A, Banerjee I, De K, Munda RN, Chattopadhayay S, Samanta A, Sarkar B, Ganguly S, Misra M.
    Amino Acids; 2013 Mar 23; 44(3):933-46. PubMed ID: 23090293
    [Abstract] [Full Text] [Related]

  • 16. Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice.
    Vilchis-Juárez A, Ferro-Flores G, Santos-Cuevas C, Morales-Avila E, Ocampo-García B, Díaz-Nieto L, Luna-Gutiérrez M, Jiménez-Mancilla N, Pedraza-López M, Gómez-Oliván L.
    J Biomed Nanotechnol; 2014 Mar 23; 10(3):393-404. PubMed ID: 24730235
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
    Hernández-Cairo A, Perera-Pintado A, Prats-Capote A, Batista-Cuellar JF, Casacó-Santana C.
    Rev Esp Med Nucl Imagen Mol; 2012 Mar 23; 31(2):61-5. PubMed ID: 22305264
    [Abstract] [Full Text] [Related]

  • 18. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
    Karczmarczyk U, Garnuszek P, Maurin M, Di Gialleonardo V, Galli F, Signore A, Mikołajczak R.
    Nucl Med Biol; 2010 Oct 23; 37(7):795-803. PubMed ID: 20870154
    [Abstract] [Full Text] [Related]

  • 19. Design of a New 99mTc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation.
    Hassanzadeh L, Erfani M, Jokar S, Shariatpanahi M.
    Curr Radiopharm; 2024 Oct 23; 17(1):77-90. PubMed ID: 37921191
    [Abstract] [Full Text] [Related]

  • 20. A freeze-dried kit formulation for the preparation of Lys(27)(99mTc-EDDA/HYNIC)-Exendin(9-39)/99mTc-EDDA/HYNIC-Tyr3-Octreotide to detect benign and malignant insulinomas.
    Medina-García V, Ocampo-García BE, Ferro-Flores G, Santos-Cuevas CL, Aranda-Lara L, García-Becerra R, Ordaz-Rosado D, Melendez-Alafort L.
    Nucl Med Biol; 2015 Dec 23; 42(12):911-6. PubMed ID: 26364504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.